AR008176A1 - Forma de dosificacion oral de liberacion controlada y uso de la misma para la fabricacion de medicamentos - Google Patents

Forma de dosificacion oral de liberacion controlada y uso de la misma para la fabricacion de medicamentos

Info

Publication number
AR008176A1
AR008176A1 ARP970104130A ARP970104130A AR008176A1 AR 008176 A1 AR008176 A1 AR 008176A1 AR P970104130 A ARP970104130 A AR P970104130A AR P970104130 A ARP970104130 A AR P970104130A AR 008176 A1 AR008176 A1 AR 008176A1
Authority
AR
Argentina
Prior art keywords
medicines
manufacture
dosage form
oral dosage
same
Prior art date
Application number
ARP970104130A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of AR008176A1 publication Critical patent/AR008176A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ARP970104130A 1996-09-12 1997-09-10 Forma de dosificacion oral de liberacion controlada y uso de la misma para la fabricacion de medicamentos AR008176A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619074.9A GB9619074D0 (en) 1996-09-12 1996-09-12 Composition

Publications (1)

Publication Number Publication Date
AR008176A1 true AR008176A1 (es) 1999-12-09

Family

ID=10799833

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104130A AR008176A1 (es) 1996-09-12 1997-09-10 Forma de dosificacion oral de liberacion controlada y uso de la misma para la fabricacion de medicamentos

Country Status (22)

Country Link
EP (1) EP0929301A2 (cs)
JP (1) JP2001500150A (cs)
KR (1) KR20000036039A (cs)
CN (2) CN1235544A (cs)
AR (1) AR008176A1 (cs)
AU (1) AU724086B2 (cs)
BR (1) BR9711734A (cs)
CA (1) CA2265661A1 (cs)
CO (1) CO5031291A1 (cs)
CZ (1) CZ83299A3 (cs)
GB (1) GB9619074D0 (cs)
HU (1) HUP9904401A3 (cs)
ID (1) ID19589A (cs)
IL (1) IL128781A0 (cs)
MA (1) MA24359A1 (cs)
NO (1) NO991194D0 (cs)
NZ (1) NZ334268A (cs)
PE (1) PE2499A1 (cs)
PL (1) PL332074A1 (cs)
TR (1) TR199900505T2 (cs)
WO (1) WO1998010762A2 (cs)
ZA (1) ZA978133B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
EP1061918A1 (en) * 1998-03-11 2000-12-27 Smithkline Beecham Plc Controlled release composition of (1-azabicyclo(2.2.2)oct-3-yl)acetonitrile monohydrochloride
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
PA8578501A1 (es) 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
KR101139744B1 (ko) 2003-04-25 2012-04-26 미쓰비시 타나베 파마 코퍼레이션 알킬렌 디옥시벤젠 유도체 함유 경구 투여용 조성물
US20070009596A1 (en) * 2003-05-14 2007-01-11 Bruschi Stefano D L Controlled drug release composition resistant to in vivo mechanic stress
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
JP2005272347A (ja) * 2004-03-24 2005-10-06 Ohara Yakuhin Kogyo Kk 固形製剤の製造方法
ME01442B (me) 2004-08-13 2013-12-20 Boehringer Ingelheim Int Tabletna formulacija sa produženim otpuštanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatuivu so, postupak za proizvodnju iste i njena primjena
EA201001086A1 (ru) * 2004-08-13 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
US9132096B1 (en) 2014-09-12 2015-09-15 Alkermes Pharma Ireland Limited Abuse resistant pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0392803T3 (da) * 1989-04-13 2004-10-18 Beecham Group Plc Hidtil ukendte forbindelser
GB9409718D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
AR004178A1 (es) * 1995-07-29 1998-11-04 Smithkline Beecham Plc Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.

Also Published As

Publication number Publication date
HUP9904401A2 (hu) 2000-06-28
IL128781A0 (en) 2000-01-31
NO991194L (no) 1999-03-11
GB9619074D0 (en) 1996-10-23
CZ83299A3 (cs) 1999-08-11
WO1998010762A2 (en) 1998-03-19
ZA978133B (en) 1999-04-12
PE2499A1 (es) 1999-03-24
CO5031291A1 (es) 2001-04-27
AU724086B2 (en) 2000-09-14
NZ334268A (en) 2000-10-27
TR199900505T2 (cs) 1999-06-21
BR9711734A (pt) 1999-08-24
JP2001500150A (ja) 2001-01-09
CA2265661A1 (en) 1998-03-19
PL332074A1 (en) 1999-08-30
EP0929301A2 (en) 1999-07-21
NO991194D0 (no) 1999-03-11
KR20000036039A (ko) 2000-06-26
CN1235544A (zh) 1999-11-17
WO1998010762A3 (en) 1998-06-04
CN1446535A (zh) 2003-10-08
ID19589A (id) 1998-07-23
MA24359A1 (fr) 1998-07-01
HUP9904401A3 (en) 2001-03-28
AU4128897A (en) 1998-04-02

Similar Documents

Publication Publication Date Title
AR008176A1 (es) Forma de dosificacion oral de liberacion controlada y uso de la misma para la fabricacion de medicamentos
ATE200981T1 (de) Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat
ES2191682T3 (es) Nueva formulacion farmaceutica.
DE69514087D1 (de) Pharmazeutisch aktive substituierte aromatische verbindungen
ATE312602T1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
FI951901L (fi) Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
SE9102072L (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
ATA106594A (de) Pharmazeutische orale zusammensetzung enthaltend verbindungen der rapamycinklasse
IL110014A0 (en) Solid controlled-release oral dosage forms
PL341055A1 (en) Novel form of a drug for oral administration of active compounds being unstable in acid environments
NO308107B1 (no) Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
ATA129892A (de) Pharmazeutische zusammensetzung
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
IS3878A (is) Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja
PT1077703E (pt) Formas de medicamentos orais com libertacao reproduzivel da substancia activa gatifloxacina ou de seus sais ou hidratos farmaceuticamente aceitaveis
ATE260262T1 (de) Pharmazeutische wirksame benzochinazolin verbindungen
NO934196D0 (no) N,N-disubstituerte arylcykloalkylaminer, deres salter, legemidler inneholdende disse forbindelser, deres anvendelseog fremgangsm}te for deres fremstilling
IT1301968B1 (it) Derivati di eritromicina ad attivita' antibiotica
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
NO940844D0 (no) Farmasöytisk aktive hydroksykarboksylsyrederivater
ITMI912044A0 (it) Composizione farmaceutica solida per uso orale a base di dapiprazolo
IT9020943A0 (it) Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei

Legal Events

Date Code Title Description
FA Abandonment or withdrawal